Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0001036050-98-000415
Filing Date
1998-03-20
Accepted
1998-03-20 00:00:00
Documents
12
Period of Report
1997-12-31
SROs
AMEX

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K405 288336
2 THIRD AMENDMENT TO LEASE AGREEMENT EX-10.3.3 7834
3 FOURTH AMENDMENT TO LEASE AGREEMENT EX-10.3.4 2735
4 AMENDED AND RESTATED LICENSE AGREEMENT EX-10.15 77225
5 LICENSE AGREEMENT EX-10.27 70177
6 AMENDMENT EX-10.27.1 2947
7 AGREEMENT EX-10.28.1 22418
8 EXECUTIVE SEVERENCE AGREEMENT WITH C. BOYD CLARKE EX-10.39 71904
9 AGREEMENT DATED AS OF MARCH 4, 1996 EX-10.40.1 6967
10 SUBSIDIARIES OF THE REGISTRANT EX-22 596
11 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS EX-23 1293
12 FINANCIAL DATA SCHEDULE EX-27 2314
  Complete submission text file 0001036050-98-000415.txt   557425
Mailing Address ONE TOWER BRIDGE 100 FRONT STREET WEST CONSHOHOCKEN PA 19428
Business Address ONE TOWER BRIDGE 100 FRONT ST WEST CONSHOHOCKEN PA 19428 6108320570
U S BIOSCIENCE INC (Filer) CIK: 0000847562 (see all company filings)

EIN.: 232460100 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 001-10392 | Film No.: 98569873
SIC: 2834 Pharmaceutical Preparations